Reuters – Bayer AG on Monday faced a second U.S. jury over allegations that its popular glyphosate-based weed killer Roundup causes cancer, six months after the company’s share price was rocked by a $289 million verdict in California state court.
The Duke Chronicle – A tumor removal tool created at Duke was recently designated a “Breakthrough Device" by the U.S. Food and Drug Administration. This device—called the "Tumor Monorail"—was designed by the Bellamkonda Lab. It works by mimicking the white matter fibers in the brain to trick tumors into moving to locations more accessible by surgeons.
BBC News – Researchers have genetically modified chickens that can lay eggs that contain drugs for arthritis and some cancers. The drugs are 100 times cheaper to produce when laid than when manufactured in factories.
STAT – A virtual reality headset allowed a mesothelioma patient to see how radiation is very precisely applied to the lining of his lungs.
Science Daily – A global resource that includes data on thousands of inherited variants in the BRCA1 and BRCA2 genes is available to the public. The BRCA Exchange was created through the BRCA Challenge, a long-term demonstration project initiated by the Global Alliance for Genomics and Health (GA4GH) to enhance sharing of BRCA1 and BRCA2 data.
STAT – Lower smoking rates are translating into fewer deaths. Advances in early detection and treatment also are having a positive impact, experts say. But it’s not all good news. Obesity-related cancer deaths are rising, and prostate cancer deaths are no longer dropping.
Phys.org – Billingsley received a nanoparticle infusion Nov. 27 and underwent a laser ablation procedure Nov. 28 as a part of clinical trials at the University of Texas Health Science Center in Houston. An MRI the next week showed no signs of cancer.
ScienceNews – Collecting cancer cells from patients and growing them into 3-D mini tumors could make it possible to quickly screen large numbers of potential drugs for ultra-rare cancers.
Science – A new study suggests that in the case of one chemotherapy drug, the debilitating side effect “chemo brain" – which affects millions of cancer patients and causes memory lapses, trouble concentrating, and an all-around mental fog – may be due to brain cells called microglia that orchestrate chemo brain by disrupting other cells that help maintain the brain’s communication system.
Associated Press – Kite, a Gilead Company, announced two-year efficacy and safety data from the pivotal ZUMA-1 trial of Yescarta ® (axicabtagene ciloleucel) in patients with refractory large B-cell lymphoma.